The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
DAVE INC CLASS A COM NEW 23834J201   50,646,111 582,675 SH   SOLE   582,675 0 0
GROVE COLLABORATIVE HOLD INC COM CL A 39957D201   4,091,496 2,943,522 SH   SOLE   2,943,522 0 0
MBX BIOSCIENCES INC COM 55287L101   39,372,654 2,136,335 SH   SOLE   2,136,335 0 0
OPENDOOR TECHNOLOGIES INC COM 683712103   6,703,299 4,189,562 SH   SOLE   4,189,562 0 0
TALKSPACE INC COM 87427V103   45,432,183 14,702,972 SH   SOLE   14,702,972 0 0
UDEMY INC COM 902685106   25,634,244 3,114,732 SH   SOLE   3,114,732 0 0
ZENAS BIOPHARMA INC COM 98937L105   15,057,168 1,838,482 SH   SOLE   1,838,482 0 0